Community pharmacies as sites of adult vaccination: A systematic review

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 12, 2016, Pages 3146-3159

  Burson, Randall C ^a   Buttenheim, Alison M ^b   Armstrong, Allison ^b   Feemster, Kristen A ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

community pharmacy services; health services delivery; immunization programs, pharmacies; vaccine policy

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; HUMAN; IMMUNIZATION; META ANALYSIS; PATIENT EDUCATION; PUBLIC HEALTH SERVICE; REVIEW; SYSTEMATIC REVIEW; TRAINING; VACCINATION; ADULT; HEALTH CARE DELIVERY; HEALTH CARE POLICY; PATIENT ATTITUDE; PHARMACY; UTILIZATION;

ADULT; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PHARMACIES; VACCINATION;

EID: 85007439571     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1215393     Document Type: Review

References (81)

1. Kamal KM, Madhavan SS, Maine LL. Pharmacy and immunization services:pharmacists' participation and impact. J Am Pharm Assoc 2003; 43(4):470-82; http://dx.doi.org/10.1331/154434503322226211; http://173.193.11.207/data/Journals/JAPhA/20401/10.1331_154434503322226211.pdf (accessed July3, 2013)
2. Capurso KA, Powers MF. Barriers to implementing a phamacist-run immunization service, as perceived by pharmacists, in a community pharmacy chain. J Pharm Technol 2006; 22(2):91-4; http://dx.doi.org/10.1177/875512250602200204
3. National Center for Health Statistics. Healthy People 2010 Final Review. US Department of Health and Human Services. 2012. http://www.cdc.gov/nchs/healthy_people/hp2010/hp2010_final_review.htm (accessed June26, 2016)
4. National Center for Health Statistics. Healthy People 2000 Final Review. US Department of Health and Human Services. 2001. http://www.cdc.gov/nchs/healthy_people/hp2010/hp2010_final_review.htm (accessed June26, 2016)
5. Williams WW, Lu P-J, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, et al. Surveillance of vaccination coverage among adult populations — United States, 2014. MMWR Surveill Summ 2016; 65(1):1-36; PMID:26844596; http://dx.doi.org/10.15585/mmwr.ss6501a1
6. Office of Disease Prevention and Health Promotion. Healthy People 2020, Objctives IID 1.1–33. US Department of Health and Human Services. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives (accessed June 26, 2016)
7. Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008; 121(7 Suppl 2):S28-S35; PMID:18589065; http://dx.doi.org/10.1016/j.amjmed.2008.05.005
8. Bodenheimer T. Primary Care — Will It Survive? N Engl J Med 2006; 355(9):861-4; PMID:16943396; http://dx.doi.org/10.1056/NEJMp068155
9. Centers for Disease Control and Prevention. Adult immunization programs in nontraditional settings:quality standards and guidance for program evaluation. Morb Mortal Wkly Rep 2000; 49:243-8.
10. Skelton JB. American Pharmacists Association, Academy of Managed Care Pharmacy. Pharmacist-provided immunization compensation and recognition:white paper summarizing APhA/AMCP stakeholder meeting. J Am Pharm Assoc JAPhA 2011; 51(6):704-12; http://dx.doi.org/10.1331/JAPhA.2011.11544
11. National Association of Chain Drug Stores. RxIMPACT 2014:community pharmacy fills gaps in access and affordability for patients, payers. 2013. http://www.drugstorenews.com/sites/drugstorenews.com/files/RxImpact_2014.pdf (accessed January9, 2015)
12. Mehrotra A, Lave JR. Visits to retail clinics grew fourfold from 2007 to 2009, although their share of overall outpatient visits remains low. Health Aff (Millwood) 2012; 31(9):2123-9; PMID:22895454; http://dx.doi.org/10.1377/hlthaff.2011.1128
13. Mehrotra A, Liu H, Adams JL, Wang MC, Lave JR, Thygeson NM, Solberg LI, McGlynn EA. Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses. Ann Intern Med 2009; 151(5):321-8; PMID:19721020; http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00006
14. Maine LL, Knapp KK, Scheckelhoff DJ. Analysis & commentary:Pharmacists and technicians can enhance patient care even more once national policies, practices, and priorities are aligned. Health Aff (Millwood) 2013; 32(11):1956-62; PMID:24191086; http://dx.doi.org/10.1377/hlthaff.2013.0529
15. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations:a decade of professional advancement. J Am Pharm Assoc JAPhA 2006; 46(2):168-79; quiz 179-182; http://dx.doi.org/10.1331/154434506776180621
16. Grabenstein JD. Pharmacists and immunization:increasing involvement over a century. Pharm Hist 1999; 41(4):137-52; PMID:11624486
17. Grabenstein JD. Daily versus single-day offering of influenza vaccine in community pharmacies. J Am Pharm Assoc 2009; 49(5):628-31; http://dx.doi.org/10.1331/JAPhA.2009.08118
18. Rothholz MC. Role of community pharmacies/pharmacists in vaccine delivery in the United States. 2013. http://www.pharmacist.com/role-community-pharmaciespharmacists-vaccine-delivery-united-states-0 (accessed February 2, 2016)
19. American Pharmacists Association. Pharmacist authority to immunize. 2016. http://www.pharmacist.com/sites/default/files/files/Slides%20on%20Pharmacist%20IZ%20Authority_2_1_16.pptx?dfptag=imz (accessed June17, 2016)
20. American Pharmacists Association. 2015 Annual Report:Expanding Opportunities through Patient Care. 2015. http://www.pharmacist.com/hero/2015-annual-report (accessedJune17, 2016)
21. Keely JL, Herald MT, Harris JP, American College of Physicians-American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med 2002; 136(1):79-85.
22. Kennedy ED, Santibanez TA, Bridges CB, Singleton JA. Flu vaccination coverage, national flu survey, March 2012. Centers for Disease Control and Prevention. 2012. http://www.cdc.gov/flu/fluvaxview/nfs-survey-march2012.htm#place (accessed September 1, 2015)
23. Singhal PK, Zhang D. Costs of adult vaccination in medical settings and pharmacies:an observational study. J Manag Care Pharm JMCP 2014; 20(9):930-6.
24. Goad JA, Taitel MS, Fensterheim LE, Cannon AE. Vaccinations administered during off-clinic hours at a national community pharmacy:implications for increasing patient access and convenience. Ann Fam Med 2013; 11(5):429-36; PMID:24019274; http://dx.doi.org/10.1370/afm.1542
25. Murphy PA, Frazee SG, Cantlin JP, Cohen E, Rosan JR, Harshburger DE. Pharmacy provision of influenza vaccinations in medically underserved communities. J Am Pharm Assoc 2012; 52(1):67-70; http://dx.doi.org/10.1331/JAPhA.2012.10070
26. Srivastav A, Santibanez TA, Kahn KE, Zhai Y, Greby SM, Bridges C, Lu P-J, Williams WW, Singleton JA, Stinger MC, et al. National early season flu vaccination coverage, United States, November 2014. Centers for Disease Control and Prevention. 2014. http://www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2014.htm (accessed January31, 2015)
27. Maine LL, Rothholz MC. Pharmacy-based immunizations–an idea whose time has come. J Am Pharm Assoc WashingtonDC 1996 2001; 41(1):13-4.
28. Tabuchi H. How CVS quit smoking and grew into a health care giant. The New York Times. 2015. http://www.nytimes.com/2015/07/12/business/how-cvs-quit-smoking-and-grew-into-a-health-care-giant.html (accessed July24, 2015)
29. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. Ann Intern Med 2009; 151(4):264-9; PMID:19622511; http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135
30. Kim DK, Bridges CB, Harriman KH, Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older — United States, 2016. MMWR Morb Mortal Wkly Rep 2016; 65(4):88-90; PMID:26845417; http://dx.doi.org/10.15585/mmwr.mm6504a5
31. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews:a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool:methodological research. J Eval Clin Pract 2012; 18(1):12-8; http://dx.doi.org/10.1111/j.1365-2753.2010.01516.x
32. Wells GA, Shea B, O'connell D, Robertson J, Peterson J, Welch V, Losos M, Tugwell P. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. http://www.medicine.mcgill.ca/rtamblyn/Readings/The%20Newcastle%20-%20Scale%20for%20assessing%20the%20quality%20of%20nonrandomised%20studies%20in%20meta-analyses.pdf (accessed January7, 2015)
33. National Institutes of Health. National Heart, Lung, and Blood Institute. Quality assessment tool for observational cohort and cross-sectional studies. 2014. http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/cohort (accessed January6, 2015)
34. Grabenstein JD, Guess HA, Hartzema AG, Koch GG, Konrad TR. Effect of vaccination by community pharmacists among adult prescription recipients. Med Care 2001; 39(4):340-8; PMID:11329521; http://dx.doi.org/10.1097/00005650-200104000-00005
35. Grabenstein JD, Guess HA, Hartzema AG, Koch GG, Konrad TR. Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated. J Clin Epidemiol 2002; 55(3):279-84; PMID:11864799; http://dx.doi.org/10.1016/S0895-4356(01)00452-8
36. Steyer TE, Ragucci KR, Pearson WS, Mainous AG, III. The role of pharmacists in the delivery of influenza vaccinations. Vaccine 2004; 22(8):1001-6; PMID:15161077; http://dx.doi.org/10.1016/j.vaccine.2003.08.045
37. Bearden DT, Holt T. Statewide impact of pharmacist-delivered adult influenza vaccinations. Am J Prev Med 2005; 29(5):450-2; PMID:16376709; http://dx.doi.org/10.1016/j.amepre.2005.08.003
38. Kummer GL, Foushee LL. Description of the characteristics of pharmacist-based immunization services in North Carolina:results of a pharmacist survey. J Am Pharm Assoc 2008; 48(6):744-51; http://dx.doi.org/10.1331/JAPhA.2008.07080
39. Pilisuk T, Goad J, Backer H. Vaccination delivery by chain pharmacies in California:results of a 2007 survey. J Am Pharm Assoc 2010; 50(2):134-9; http://dx.doi.org/10.1331/JAPhA.2010.09168
40. Pace AC, Flowers SK, Hastings JK. Arkansas community pharmacists' opinions on providing immunizations. J Pharm Pract 2010; 23(5):496-501; PMID:21507853; http://dx.doi.org/10.1177/0897190010362105
41. Weitzel KW, Goode JV. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc 2000; 40(2):252-6; http://dx.doi.org/10.1016/S1086-5802(16)31066-X
42. Penfold RB, Rusinak D, Lieu TA, Shefer A, Messonnier M, Lee GM. Financing and systems barriers to seasonal influenza vaccine delivery in community settings. Vaccine 2011; 29(52):9632-9; PMID:22036886; http://dx.doi.org/10.1016/j.vaccine.2011.10.041
43. Madhavan SS, Rosenbluth SA, Amonkar M, Borker RD, Richards T. Pharmacists and immunizations:a national survey. J Am Pharm Assoc 2001; 41(1):32-45; http://dx.doi.org/10.1016/S1086-5802(16)31203-7
44. Turner CJ, Ellis S, Giles J, Altiere R, Sintek C, Ulrich H, Valdez C, Zadvorny E. An introductory pharmacy practice experience emphasizing student-administered vaccinations. Am J Pharm Educ 2007; 71(1):3; PMID:17429503
45. Teeter BS, Garza KB, Stevenson TL, Williamson MA, Zeek ML, Westrick SC. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies. Vaccine 2014; 32(43):5749-54; PMID:25171848; http://dx.doi.org/10.1016/j.vaccine.2014.08.040
46. Doucette WR, Kreling DH, Schommer JC, Gaither CA, Mott DA, Pedersen CA. Evaluation of community pharmacy service mix:Evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc 2006; 46(3):348-55; http://dx.doi.org/10.1331/154434506777069471
47. Westrick SC, Mount JK, Watcharadamrongkun S, Breland ML. Pharmacy stages of involvement in pharmacy-based immunization services:results from a 17-state survey. J Am Pharm Assoc 2008; 48(6):764-73; http://dx.doi.org/10.1331/JAPhA.2008.07118
48. Neuhauser MM, Wiley D, Simpson L, Garey KW. Involvement of immunization-certified pharmacists with immunization activities. Ann Pharmacother 2004; 38(2):226-31; PMID:14742755; http://dx.doi.org/10.1345/aph.1D257
49. Goode J-VR, Mott DA, Stanley DD. Assessment of an immunization program in a supermarket chain pharmacy. J Am Pharm Assoc 2007; 47(4):495-8; http://dx.doi.org/10.1331/JAPhA.2007.06100
50. Westrick SC. Pharmacy characteristics, vaccination service characteristics, and service expansion:an analysis of sustainers and new adopters. J Am Pharm Assoc 2010; 50(1):52-61; http://dx.doi.org/10.1331/JAPhA.2010.09036
51. Kamal KM, Madhavan SS, Maine LL. Impact of the American pharmacists association's (APhA) immunization training certification program. Am J Pharm Educ 2003; 67(4); http://dx.doi.org/10.5688/aj6704124
52. Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree:Standards 2016. Chicago, IL:Accreditation Coucil for Pharmacy Education; 2015. https://www.acpe-accredit.org/pdf/Standards2016FINAL.pdf (accessed June19, 2016)
53. Westrick SC, Mount J, Watcharadamrongkun S. College/school of pharmacy affiliation and community pharmacies' involvement in public health activities. Am J Pharm Educ 2009; 73(7):123; PMID:19960082; http://dx.doi.org/10.5688/aj7307123
54. Westrick SC, Watcharadamrongkun S, Mount JK, Breland ML. Community pharmacy involvement in vaccine distribution and administration. Vaccine 2009; 27(21):2858-63; PMID:19428895; http://dx.doi.org/10.1016/j.vaccine.2009.02.086
55. Westrick SC. Forward and backward transitions in pharmacy-based immunization services. Res Soc Adm Pharm 2010; 6(1):18-31; http://dx.doi.org/10.1016/j.sapharm.2009.02.001
56. Westrick SC, Breland ML. Sustainability of pharmacy-based innovations:the case of in-house immunization services. J Am Pharm Assoc 2009; 49(4):500-8; http://dx.doi.org/10.1331/JAPhA.2009.08055
57. Westrick SC, Owen J, Hagel H, Owensby JK, Lertpichitkul T. Impact of the RxVaccinate program for pharmacy-based pneumococcal immunization:A cluster-randomized controlled trial. J Am Pharm Assoc JAPhA 2016; 56(1):29-36.e1; http://dx.doi.org/10.1016/j.japh.2015.11.010
58. Westrick SC, Mount JK. Impact of perceived innovation characteristics on adoption of pharmacy-based in-house immunization services. Int J Pharm Pract 2009; 17(1):39-46; PMID:20218028; http://dx.doi.org/10.1211/ijpp.17.1.0006
59. Crawford ND, Blaney S, Amesty S, Rivera AV, Turner AK, Ompad DC, Fuller CM. Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies:pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City. J Urban Health Bull N Y Acad Med 2011; 88(1):176-85; http://dx.doi.org/10.1007/s11524-010-9541-6
60. Centers for Medicare & Medicaid Services. Vaccine and vaccine administration payments under Medicare Part D. MLN Matters. 2015. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/Downloads/Vaccines-Part-D-Factsheet-ICN908764.pdf (accessed February 2, 2016)
61. Cigna. Cigna medical vaccine program directory. 2015. https://my.cigna.com/teamsitepublic/js/partner/bni/833008_CIGNA_Pharmacy_Vaccine_Program_Directory.pdf (accessed February 2, 2016)
62. UnitedHealthCare. Adult vaccinations. June 2015. http://consultant.uhc.com/assets/FINAL%20100-13060-external-adult-vaccination-flier-2015.pdf (accessed January31, 2015)
63. Wood HM, McDonough RP, Doucette WR. Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective. J Am Pharm Assoc 2009; 49(1):12-7; http://dx.doi.org/10.1331/JAPhA.2009.08030
64. Ernst ME, Chalstrom CV, Currie JD, Sorofman B. Implementation of a community pharmacy-based influenza vaccination program. J Am Pharm Assoc 1997; 37(5):570-80; http://dx.doi.org/10.1016/S1086-5802(16)30253-4
65. Grabenstein JD, Guess HA, Hartzema AG. People vaccinated by pharmacists:descriptive epidemiology. J Am Pharm Assoc 2001; 41(1):46-52; http://dx.doi.org/10.1016/S1086-5802(16)31204-9
66. Wang J, Ford LJ, Wingate L, Uroza SF, Jaber N, Smith CT, Randolph R, Lane S, Foster SL. Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. J Am Pharm Assoc 2013; 53(1):46-53; http://dx.doi.org/10.1331/JAPhA.2013.12019
67. Ernst ME, Bergus GR, Sorofman BA. Patients' acceptance of traditional and nontraditional immunization providers. J Am Pharm Assoc 2001; 41(1):53-59; http://dx.doi.org/10.1016/S1086-5802(16)31205-0
68. Grabenstein JD, Hartzema AG, Guess HA, Johnston WP, Rittenhouse BE. Community pharmacists as immunization advocates. Cost-effectiveness of a cue to influenza vaccination. Med Care 1992; 30(6):503-13; PMID:1593916; http://dx.doi.org/10.1097/00005650-199206000-00004
69. Hedden MA, Kuehl PG, Liu Y. Economic analysis of a herpes zoster vaccination program in 19 affiliated supermarket pharmacies. J Am Pharm Assoc 2014; 5 4(4):390-6; http://dx.doi.org/10.1331/JAPhA.2014.13140
70. Bryan AR, Liu Y, Kuehl PG. Advocating zoster vaccination in a community pharmacy through use of personal selling. J Am Pharm Assoc 2013; 53(1):70-7; http://dx.doi.org/10.1331/JAPhA.2013.11097
71. Marrero W, Hernández L, García R, Gutiérrez LM. Programa de inmunización contra la influenza para adultos de 65 años o más en una farmacia de comunidad en Puerto Rico. P R Health Sci J 2006; 25(1):35-42; PMID:16883677
72. Hess R. Impact of automated telephone messaging on zoster vaccination rates in community pharmacies. J Am Pharm Assoc 2013; 53(2):182-7; http://dx.doi.org/10.1331/JAPhA.2013.12222
73. Brackett A, Butler M, Chapman L. Using motivational interviewing in the community pharmacy to increase adult immunization readiness:A pilot evaluation. J Am Pharm Assoc JAPhA 2015; 55(2):182-6; http://dx.doi.org/10.1331/JAPhA.2015.14120
74. Prosser LA, O'Brien MA, Molinari N-AM, Hohman KH, Nichol KL, Messonnier ML, Lieu TA. Non-traditional settings for influenza vaccination of adults:costs and cost effectiveness. PharmacoEconomics 2008; 26(2):163-78; PMID:18198935; http://dx.doi.org/10.2165/00019053-200826020-00006
75. Doucette WR, McDonough RP, Mormann MM, Vaschevici R, Urmie JM, Patterson BJ. Three-year financial analysis of pharmacy services at an independent community pharmacy. J Am Pharm Assoc 2012; 52(2):181-7; http://dx.doi.org/10.1331/JAPhA.2012.11207
76. Erickson SR, Workman P. Services provided by community pharmacies in Wayne County, Michigan:a comparison by ZIP code characteristics. J Am Pharm Assoc JAPhA 2014; 54(6):618-24; http://dx.doi.org/10.1331/JAPhA.2014.14105
77. Wang J, Munshi KD, Hong SH. Racial and ethnic disparities in influenza vaccinations among community pharmacy patients and non-community pharmacy respondents. Res Soc Adm Pharm 2013; 10(1):126-40; http://dx.doi.org/10.1016/j.sapharm.2013.04.011
78. Taitel M, Cohen E, Duncan I, Pegus C. Pharmacists as providers:targeting pneumococcal vaccinations to high risk populations. Vaccine 2011; 29(45):8073-6; PMID:21864625; http://dx.doi.org/10.1016/j.vaccine.2011.08.051
79. Ko KJ, Wade RL, Yu HT, Miller RM, Sherman B, Goad J. Implementation of a pharmacy-based adult vaccine benefit:Recommendations for a commercial health plan benefit. J Manag Care Pharm 2014; 20(3):273-82.
80. Shaw FE, Asomugha CN, Conway PH, Rein AS. The Patient Protection and Affordable Care Act:opportunities for prevention and public health. The Lancet 2014; 384(9937):75-82; http://dx.doi.org/10.1016/S0140-6736(14)60259-2
81. Koh HK, Sebelius KG. Promoting prevention through the affordable care act. N Engl J Med 2010; 363(14):1296-9; PMID:20879876; http://dx.doi.org/10.1056/NEJMp1008560